Open AccessAdjuvant Olaparib Improves Disease-Free Survival in Early Breast Cancer
Author(s) -
Mark L. Fuerst
Publication year - 2021
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000771908.13436.7c
Subject(s) - olaparib , medicine , breast cancer , oncology , parp inhibitor , cancer , brca mutation , clinical trial , biochemistry , chemistry , polymerase , poly adp ribose polymerase , gene